CD44 is a multidomain signaling platform that integrates extracellular matrix cues with growth factor and cytokine signals

Advances in Cancer Research

Volumn 123, Issue , 2014, Pages 231-254

  Orian Rousseau, Véronique ^a   Sleeman, Jonathan ^a,b  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CD44; Chemokines; Growth factors; Hyaluronan; Receptor tyrosine kinases; Signaling

Indexed keywords

CELL SURFACE RECEPTOR; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; HERMES ANTIGEN; HYALURONIC ACID; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; SCATTER FACTOR RECEPTOR; VASCULOTROPIN RECEPTOR; CD44 PROTEIN, HUMAN; CHEMOKINE; LIGAND; SCATTER FACTOR; SIGNAL PEPTIDE;

ARTICLE; CELL COMPONENT; CELL FUNCTION; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT; ALTERNATIVE RNA SPLICING; ANIMAL; CELL MEMBRANE; CHEMISTRY; CYTOPLASM; METABOLISM; NEOPLASM; PROTEIN TERTIARY STRUCTURE;

ALTERNATIVE SPLICING; ANIMALS; ANTIGENS, CD44; CELL MEMBRANE; CHEMOKINES; CYTOKINES; CYTOPLASM; EXTRACELLULAR MATRIX; HEPATOCYTE GROWTH FACTOR; HUMANS; HYALURONIC ACID; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84904903610     PISSN: 0065230X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-800092-2.00009-5     Document Type: Chapter

References (106)

1. Acharya P.S., Majumdar S., Jacob M., Hayden J., Mrass P., Weninger W., et al. Fibroblast migration is mediated by CD44-dependent TGF beta activation. Journal of Cell Science 2008, 121:1393-1402.
2. Alves C.S., Konstantopoulos K. PDGF suppresses the sulfation of CD44v and potentiates CD44v-Mediated binding of colon carcinoma cells to fibrin under flow. PLoS One 2012, 7:e41472.
3. Anborgh P.H., Mutrie J.C., Tuck A.B., Chambers A.F. Role of the metastasis-promoting protein osteopontin in the tumour microenvironment. Journal of Cellular and Molecular Medicine 2010, 14:2037-2044.
4. Avigdor A., Goichberg P., Shivtiel S., Dar A., Peled A., Samira S., et al. CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow. Blood 2004, 103:2981-2989.
5. Bai Y., Liu Y.J., Wang H., Xu Y., Stamenkovic I., Yu Q. Inhibition of the hyaluronan-CD44 interaction by merlin contributes to the tumor-suppressor activity of merlin. Oncogene 2007, 26:836-850.
6. Bartolazzi A., Nocks A., Aruffo A., Spring F., Stamenkovic I. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. The Journal of Cell Biology 1996, 132:1199-1208.
7. Bennett K.L., Jackson D.G., Simon J.C., Tanczos E., Peach R., Modrell B., et al. CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor. The Journal of Cell Biology 1995, 128:687-698.
8. Bernhagen J., Krohn R., Lue H., Gregory J.L., Zernecke A., Koenen R.R., et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nature Medicine 2007, 13:587-596.
9. Bloor B.K., Jelvagharan M., White K.N., Odell E.W. Characterization of CD44 splicing patterns in normal keratinocytes, dysplastic and squamous carcinoma cell lines. International Journal of Oncology 2001, 18:1053-1059.
10. Borowiak M., Garratt A.N., Wustefeld T., Strehle M., Trautwein C., Birchmeier C. Met provides essential signals for liver regeneration. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:10608-10613.
11. Bourguignon L.Y., Gilad E., Rothman K., Peyrollier K. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression. The Journal of Biological Chemistry 2005, 280:11961-11972.
12. Bourguignon L.Y., Peyrollier K., Gilad E., Brightman A. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells. The Journal of Biological Chemistry 2007, 282:1265-1280.
13. Bourguignon L.Y., Singleton P.A., Zhu H., Zhou B. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. The Journal of Biological Chemistry 2002, 277:39703-39712.
14. Bourguignon L.Y., Zhu H., Shao L., Chen Y.W. CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. The Journal of Biological Chemistry 2000, 275:1829-1838.
15. Bourguignon L.Y., Zhu H., Shao L., Zhu D., Chen Y.W. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motility and the Cytoskeleton 1999, 43:269-287.
16. Bourguignon L.Y., Zhu H., Zhou B., Diedrich F., Singleton P.A., Hung M.C. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. The Journal of Biological Chemistry 2001, 276:48679-48692.
17. Brown K.L., Birkenhead D., Lai J.C., Li L., Li R., Johnson P. Regulation of hyaluronan binding by F-actin and colocalization of CD44 and phosphorylated ezrin/radixin/moesin (ERM) proteins in myeloid cells. Experimental Cell Research 2005, 303:400-414.
18. Burger J.A., Kipps T.J. CXCR4: A key receptor in the crosstalk between tumor cells and their microenvironment. Blood 2006, 107:1761-1767.
19. Calandra T., Roger T. Macrophage migration inhibitory factor: A regulator of innate immunity. Nature Reviews Immunology 2003, 3:791-800.
20. Candido J., Hagemann T. Cancer-related inflammation. Journal of Clinical Immunology 2013, 33(Suppl. 1):S79-S84.
21. Cecchi F., Pajalunga D., Fowler C.A., Uren A., Rabe D.C., Peruzzi B., et al. Targeted disruption of heparan sulfate interaction with hepatocyte and vascular endothelial growth factors blocks normal and oncogenic signaling. Cancer Cell 2012, 22:250-262.
22. Chung A.S., Ferrara N. Developmental and pathological angiogenesis. Annual Review of Cell and Developmental Biology 2011, 27:563-584.
23. Deribe Y.L., Pawson T., Dikic I. Post-translational modifications in signal integration. Nature Structural & Molecular Biology 2010, 17:666-672.
24. Dibble C.C., Manning B.D. Signal integration by mTORC1 coordinates nutrient input with biosynthetic output. Nature Cell Biology 2013, 15:555-564.
25. Du W., Wright B.M., Li X., Finke J., Rini B.I., Zhou M., et al. Tumor-derived macrophage migration inhibitory factor promotes an autocrine loop that enhances renal cell carcinoma. Oncogene 2013, 32:1469-1474.
26. Dudanova I., Klein R. Integration of guidance cues: Parallel signaling and crosstalk. Trends in Neurosciences 2013, 36:295-304.
27. English N.M., Lesley J.F., Hyman R. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding. Cancer Research 1998, 58:3736-3742.
28. Faassen A.E., Schrager J.A., Klein D.J., Oegema T.R., Couchman J.R., Mccarthy J.B. A cell-surface chondroitin sulfate proteoglycan, immunologically related to Cd44, is involved in Type-I collagen-mediated melanoma cell motility and invasion. Journal of Cell Biology 1992, 116:521-531.
29. Fuchs K., Hippe A., Schmaus A., Homey B., Sleeman J.P., Orian-Rousseau V. Opposing effects of high- and low-molecular weight hyaluronan on CXCL12-induced CXCR4 signaling depend on CD44. Cell Death Disease 2013, 4:e819.
30. Ghatak S., Misra S., Toole B.P. Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells. The Journal of Biological Chemistry 2005, 280:8875-8883.
31. Goldstein L.A., Zhou D.F., Picker L.J., Minty C.N., Bargatze R.F., Ding J.F., et al. A human lymphocyte homing receptor, the hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 1989, 56:1063-1072.
32. Goodison S., Urquidi V., Tarin D. CD44 cell adhesion molecules. Molecular Pathology 1999, 52:189-196.
33. Gordin M., Tesio M., Cohen S., Gore Y., Lantner F., Leng L., et al. c-Met and its ligand hepatocyte growth factor/scatter factor regulate mature B cell survival in a pathway induced by CD74. The Journal of Immunology 2010, 185:2020-2031.
34. Greenfield B., Wang W.C., Marquardt H., Piepkorn M., Wolff E.A., Aruffo A., et al. Characterization of the heparan sulfate and chondroitin sulfate assembly sites in CD44. The Journal of Biological Chemistry 1999, 274:2511-2517.
35. Groves J.T., Kuriyan J. Molecular mechanisms in signal transduction at the membrane. Nature Structural & Molecular Biology 2010, 17:659-665.
36. Gunthert U., Hofmann M., Rudy W., Reber S., Zoller M., Haussmann I., et al. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991, 65:13-24.
37. Hartmann G., Prospero T., Brinkmann V., Ozcelik C., Winter G., Hepple J., et al. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Current Biology 1998, 8:125-134.
38. Hasenauer S., Malinger D., Koschut D., Pace G., Matzke A., von Au A., et al. Internalization of Met requires the co-receptor CD44v6 and its link to ERM proteins. PLoS One 2013, 8:e62357.
39. Irvine K.D. Integration of intercellular signaling through the Hippo pathway. Seminars in Cell & Developmental Biology 2012, 23:812-817.
40. Jackson D.G. Immunological functions of hyaluronan and its receptors in the lymphatics. Immunological Reviews 2009, 230:216-231.
41. Jalkanen S., Jalkanen M. Lymphocyte Cd44 binds the cooh-terminal heparin-binding domain of fibronectin. Journal of Cell Biology 1992, 116:817-825.
42. Jones M., Tussey L., Athanasou N., Jackson D.G. Heparan sulfate proteoglycan isoforms of the CD44 hyaluronan receptor induced in human inflammatory macrophages can function as paracrine regulators of fibroblast growth factor action. The Journal of Biological Chemistry 2000, 275:7964-7974.
43. Kaindl T., Rieger H., Kaschel L.M., Engel U., Schmaus A., Sleeman J., et al. Spatio-temporal patterns of pancreatic cancer cells expressing CD44 isoforms on supported membranes displaying hyaluronic acid oligomers arrays. PLoS One 2012, 7:e42991.
44. Katagiri Y.U., Sleeman J., Fujii H., Herrlich P., Hotta H., Tanaka K., et al. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Research 1999, 59:219-226.
45. Katoh S., Zheng Z., Oritani K., Shimozato T., Kincade P.W. Glycosylation of CD44 negatively regulates its recognition of hyaluronan. The Journal of Experimental Medicine 1995, 182:419-429.
46. Kermorgant S., Parker P.J. Receptor trafficking controls weak signal delivery: A strategy used by c-Met for STAT3 nuclear accumulation. The Journal of Cell Biology 2008, 182:855-863.
47. Kholodenko B.N. Four-dimensional organization of protein kinase signaling cascades: The roles of diffusion, endocytosis and molecular motors. The Journal of Experimental Biology 2003, 206:2073-2082.
48. Kholodenko B.N., Hancock J.F., Kolch W. Signalling ballet in space and time. Nature Reviews Molecular Cell Biology 2010, 11:414-426.
49. Kim Y., Lee Y.S., Choe J., Lee H., Kim Y.M., Jeoung D. CD44-epidermal growth factor receptor interaction mediates hyaluronic acid-promoted cell motility by activating protein kinase C signaling involving Akt, Rac1, Phox, reactive oxygen species, focal adhesion kinase, and MMP-2. The Journal of Biological Chemistry 2008, 283:22513-22528.
50. Korpetinou A., Skandalis S.S., Labropoulou V.T., Smirlaki G., Noulas A., Karamanos N.K., et al. Serglycin: At the crossroad of inflammation and malignancy. Frontiers in Oncology 2014, 3:327.
51. Lefebvre J., Ancot F., Leroy C., Muharram G., Lemiere A., Tulasne D. Met degradation: More than one stone to shoot a receptor down. FASEB Journal 2012, 26:1387-1399.
52. Legg J.W., Isacke C.M. Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Current Biology 1998, 8:705-708.
53. Leng L., Metz C.N., Fang Y., Xu J., Donnelly S., Baugh J., et al. MIF signal transduction initiated by binding to CD74. The Journal of Experimental Medicine 2003, 197:1467-1476.
54. Lesley J., English N., Charles C., Hyman R. The role of the CD44 cytoplasmic and transmembrane domains in constitutive and inducible hyaluronan binding. European Journal of Immunology 2000, 30:245-253.
55. Lesley J., English N.M., Gal I., Mikecz K., Day A.J., Hyman R. Hyaluronan binding properties of a CD44 chimera containing the link module of TSG-6. The Journal of Biological Chemistry 2002, 277:26600-26608.
56. Lesley J., English N., Perschl A., Gregoroff J., Hyman R. Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. The Journal of Experimental Medicine 1995, 182:431-437.
57. Lesley J., He Q., Miyake K., Hamann A., Hyman R., Kincade P.W. Requirements for hyaluronic acid binding by CD44: A role for the cytoplasmic domain and activation by antibody. The Journal of Experimental Medicine 1992, 175:257-266.
58. Li L., Heldin C.H., Heldin P. Inhibition of platelet-derived growth factor-BB-induced receptor activation and fibroblast migration by hyaluronan activation of CD44. The Journal of Biological Chemistry 2006, 281:26512-26519.
59. Lokeshwar V.B., Bourguignon L.Y. Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. The Journal of Biological Chemistry 1991, 266:17983-17989.
60. Matzke A., Herrlich P., Ponta H., Orian-Rousseau V. A five-amino-acid peptide blocks Met- and Ron-dependent cell migration. Cancer Research 2005, 65:6105-6110.
61. Matzke A., Sargsyan V., Holtmann B., Aramuni G., Asan E., Sendtner M., et al. Haploinsufficiency of c-Met in cd44-/- mice identifies a collaboration of CD44 and c-Met in vivo. Molecular and Cellular Biology 2007, 27:8797-8806.
62. McNeill H., Woodgett J.R. When pathways collide: Collaboration and connivance among signalling proteins in development. Nature Reviews Molecular Cell Biology 2010, 11:404-413.
63. Meran S., Luo D.D., Simpson R., Martin J., Wells A., Steadman R., et al. Hyaluronan facilitates transforming growth factor-beta1-dependent proliferation via CD44 and epidermal growth factor receptor interaction. The Journal of Biological Chemistry 2011, 286:17618-17630.
64. Morrison H., Sherman L.S., Legg J., Banine F., Isacke C., Haipek C.A., et al. The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44. Genes & Development 2001, 15:968-980.
65. Naor D., Sionov R.V., IshShalom D. CD44: Structure, function, and association with the malignant process. Advances in Cancer Research 1997, 71:241-319.
66. Naujokas M.F., Morin M., Anderson M.S., Peterson M., Miller J. The chondroitin sulfate form of invariant chain can enhance stimulation of T cell responses through interaction with CD44. Cell 1993, 74:257-268.
67. Noble P.W., Jiang D. Matrix regulation of lung injury, inflammation, and repair: The role of innate immunity. Proceedings of the American Thoracic Society 2006, 3:401-404.
68. Olaku V., Matzke A., Mitchell C., Hasenauer S., Sakkaravarthi A., Pace G., et al. c-Met recruits ICAM-1 as a coreceptor to compensate for the loss of CD44 in Cd44 null mice. Molecular Biology of the Cell 2011, 22:2777-2786.
69. Orian-Rousseau V. CD44, a therapeutic target for metastasising tumours. European Journal of Cancer 2010, 46:1271-1277.
70. Orian-Rousseau V., Chen L., Sleeman J.P., Herrlich P., Ponta H. CD44 is required for two consecutive steps in HGF/c-Met signaling. Genes & Development 2002, 16:3074-3086.
71. Orian-Rousseau V., Morrison H., Matzke A., Kastilan T., Pace G., Herrlich P., et al. Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin. Molecular Biology of the Cell 2007, 18:76-83.
72. Panne D. The enhanceosome. Current Opinion in Structural Biology 2008, 18:236-242.
73. Pawson C.T., Scott J.D. Signal integration through blending, bolstering and bifurcating of intracellular information. Nature Structural & Molecular Biology 2010, 17:653-658.
74. Peach R.J., Hollenbaugh D., Stamenkovic I., Aruffo A. Identification of hyaluronic acid binding sites in the extracellular domain of CD44. The Journal of Cell Biology 1993, 122:257-264.
75. Peck D., Isacke C.M. CD44 phosphorylation regulates melanoma cell and fibroblast migration on, but not attachment to, a hyaluronan substratum. Current Biology 1996, 6:884-890.
76. Peck D., Isacke C.M. Hyaluronan-dependent cell migration can be blocked by a CD44 cytoplasmic domain peptide containing a phosphoserine at position 325. Journal of Cell Science 1998, 111(Pt. 11):1595-1601.
77. Peterson R.S., Andhare R.A., Rousche K.T., Knudson W., Wang W., Grossfield J.B., et al. CD44 modulates Smad1 activation in the BMP-7 signaling pathway. The Journal of Cell Biology 2004, 166:1081-1091.
78. Ponta H., Sherman L., Herrlich P.A. CD44: From adhesion molecules to signalling regulators. Nature Reviews Molecular Cell Biology 2003, 4:33-45.
79. Purcell B.P., Elser J.A., Mu A., Margulies K.B., Burdick J.A. Synergistic effects of SDF-1alpha chemokine and hyaluronic acid release from degradable hydrogels on directing bone marrow derived cell homing to the myocardium. Biomaterials 2012, 33:7849-7857.
80. Purushothaman A., Toole B.P. Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth and vascularization. The Journal of Biological Chemistry 2014, 289:5499-5509.
81. Rao G., Wang H., Li B., Huang L., Xue D., Wang X., et al. Reciprocal interactions between tumor-associated macrophages and CD44-positive cancer cells via osteopontin/CD44 promote tumorigenicity in colorectal cancer. Clinical Cancer Research 2013, 19:785-797.
82. Ruckert F., Grutzmann R., Pilarsky C. Feedback within the inter-cellular communication and tumorigenesis in carcinomas. PLoS One 2012, 7:e36719.
83. Screaton G.R., Bell M.V., Bell J.I., Jackson D.G. The identification of a new alternative exon with highly restricted tissue expression in transcripts encoding the mouse Pgp-1 (CD44) homing receptor. Comparison of all 10 variable exons between mouse, human, and rat. The Journal of Biological Chemistry 1993, 268:12235-12238.
84. Seiter S., Tilgen W., Herrmann K., Schadendorf D., Patzelt E., Moller P., et al. Expression of CD44 splice variants in human skin and epidermal tumours. Virchows Archiv 1996, 428:141-149.
85. Sherman L.S., Rizvi T.A., Karyala S., Ratner N. CD44 enhances neuregulin signaling by Schwann cells. The Journal of Cell Biology 2000, 150:1071-1084.
86. Sherman L., Wainwright D., Ponta H., Herrlich P. Genes & Development 1998, 12:1058-1071.
87. Shi X., Leng L., Wang T., Wang W., Du X., Li J., et al. CD44 is the signaling component of the macrophage migration inhibitory factor-CD74 receptor complex. Immunity 2006, 25:595-606.
88. Sleeman J., Rudy W., Hofmann M., Moll J., Herrlich P., Ponta H. Regulated clustering of variant CD44 proteins increases their hyaluronate binding capacity. The Journal of Cell Biology 1996, 135:1139-1150.
89. Soto A.M., Sonnenschein C. The tissue organization field theory of cancer: A testable replacement for the somatic mutation theory. BioEssays 2011, 33:332-340.
90. Stamenkovic I., Yu Q. Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival. Current Protein & Peptide Science 2010, 11:471-484.
91. Sweatt J.D. The neuronal MAP kinase cascade: A biochemical signal integration system subserving synaptic plasticity and memory. Journal of Neurochemistry 2001, 76:1-10.
92. Teramoto H., Castellone M.D., Malek R.L., Letwin N., Frank B., Gutkind J.S., et al. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12. Oncogene 2005, 24:489-501.
93. Teriete P., Banerji S., Noble M., Blundell C.D., Wright A.J., Pickford A.R., et al. Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44. Molecular Cell 2004, 13:483-496.
94. Todaro M., Gaggianesi M., Catalano V., Benfante A., Iovino F., Biffoni M., et al. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell 2014, 14:342-356.
95. Tremmel M., Matzke A., Albrecht I., Laib A.M., Olaku V., Ballmer-Hofer K., et al. A CD44v6 peptide reveals a role of CD44 in VEGFR-2 signaling and angiogenesis. Blood 2009, 114:5236-5244.
96. Trofatter J.A., MacCollin M.M., Rutter J.L., Murrell J.R., Duyao M.P., Parry D.M., et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 1993, 72:791-800.
97. Underhill C. CD44: The hyaluronan receptor. Journal of Cell Science 1992, 103(Pt. 2):293-298.
98. van der Voort R., Taher T.E., Wielenga V.J., Spaargaren M., Prevo R., Smit L., et al. Heparan sulfate-modified CD44 promotes hepatocyte growth factor/scatter factor-induced signal transduction through the receptor tyrosine kinase c-Met. The Journal of Biological Chemistry 1999, 274:6499-6506.
99. Wai P.Y., Kuo P.C. Osteopontin: Regulation in tumor metastasis. Cancer Metastasis Reviews 2008, 27:103-118.
100. Weber G.F., Ashkar S., Glimcher M.J., Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science 1996, 271:509-512.
101. Wielenga V.J., Heider K.H., Offerhaus G.J., Adolf G.R., van den Berg F.M., Ponta H., et al. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Research 1993, 53:4754-4756.
102. Wiley H.S., Burke P.M. Regulation of receptor tyrosine kinase signaling by endocytic trafficking. Traffic 2001, 2:12-18.
103. Yoo B.K., Gredler R., Chen D., Santhekadur P.K., Fisher P.B., Sarkar D. c-Met activation through a novel pathway involving osteopontin mediates oncogenesis by the transcription factor LSF. Journal of Hepatology 2011, 55:1317-1324.
104. Yu Q., Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes & Development 1999, 13:35-48.
105. Yu W.H., Woessner J.F., McNeish J.D., Stamenkovic I. CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes & Development 2002, 16:307-323.
106. Zeilstra J., Joosten S.P., van Andel H., Tolg C., Berns A., Snoek M., et al. Stem cell CD44v isoforms promote intestinal cancer formation in Apc(min) mice downstream of Wnt signaling. Oncogene 2014, 33:665-670.